Abiopharma

New Form 4 - SELECT MEDICAL HOLDINGS CORP Filed: 2025-08-04 AccNo: 0001415889-25-020954 Size: 4 KB

New Form 4 - ENSIGN GROUP, INC Filed: 2025-08-04 AccNo: 0001125376-25-000145 Size: 4 KB

New Form 4 - Medtronic plc Filed: 2025-08-04 AccNo: 0001613103-25-000130 Size: 15 KB

New Form 144 - FATE THERAPEUTICS INC Filed: 2025-08-04 AccNo: 0001959173-25-004926 Size: 4 KB

New Form 10-Q - Inspire Medical Systems, Inc. Filed: 2025-08-04 AccNo: 0001609550-25-000032 Size: 7 MB

New Form 4 - SELECT MEDICAL HOLDINGS CORP Filed: 2025-08-04 AccNo: 0001415889-25-020952 Size: 7 KB

Myomo to Report Second Quarter 2025 Financial Results on August 11

New Form 4 - ELI LILLY & Co Filed: 2025-08-04 AccNo: 0000059478-25-000198 Size: 8 KB

New Form 4 - Medtronic plc Filed: 2025-08-04 AccNo: 0001613103-25-000129 Size: 10 KB

New Form 8-K - Addus HomeCare Corp Filed: 2025-08-04 AccNo: 0001437749-25-024617 Size: 711 KB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Bristol Myers Squibb - Bristol Myers Squibb’sApplication for Breyanzi (lisocabtagene maraleucel) Accepted for Priority Review by U.S. Food and Drug Administration (FDA) in Fifth Cancer Type for Relapsed or Refractory Marginal Zone Lymphoma (MZL)

New Form 3 - ROCKET PHARMACEUTICALS, INC. Filed: 2025-08-04 AccNo: 0001140361-25-028612 Size: 20 KB

New Form 4 - SELECT MEDICAL HOLDINGS CORP Filed: 2025-08-04 AccNo: 0001415889-25-020950 Size: 4 KB

New Form 10-Q - agilon health, inc. Filed: 2025-08-04 AccNo: 0001628280-25-037430 Size: 7 MB

New Form 4 - Medtronic plc Filed: 2025-08-04 AccNo: 0001613103-25-000128 Size: 20 KB